Item 8.01  Other Events.
On January 14, 2020, Denali Therapeutics Inc. (the "Company") issued a press
release announcing positive clinical results from its LRRK2 program for
Parkinson's disease in addition to IND and CTA submissions for two additional
programs. A copy of the press release is attached hereto as Exhibit 99.1 to this
Current Report on Form 8-K and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit No.       Description
99.1                Press Release dated     Januar    y     14    , 20    20    .

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses